Press Releases

Date Title
9/3/19 Sarepta Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference
8/30/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
8/19/19 Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application
8/8/19 Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS)
8/7/19 Sarepta Therapeutics Announces Second Quarter 2019 Financial Results and Recent Corporate Developments
7/31/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7/31/19 Sarepta Therapeutics to Announce Second Quarter 2019 Financial Results and Recent Corporate Developments on August 7, 2019
6/28/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6/4/19 Sarepta Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference
5/31/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Displaying 81 - 90 of 670